Calcium channel inhibitors
US11130750B2 · kind B2 · utility
0Cited by
6References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2018 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Feb 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D235/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure describes carbamate analogs of mibefradil, as well as their compositions and methods of use. The compounds block the activity of one or more isoforms of voltage-gated calcium channels and are useful in the treatment of diseases including, e.g., cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.